Patents by Inventor John Gillespie

John Gillespie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210110474
    Abstract: Blockchain, or distributed ledger network technology, facilitates and accelerates foreign currency (FX) transactions and makes them reliable and trusted by prequalifying participants in the transactions to participate. Prequalifying participants enables funding of the transaction before parties enter into a trade, reducing the time required to consummate a transaction. In one aspect, the credit aspect of these transactions is disaggregated from the transactions themselves, eliminating credit risk and delivery risk, among others. Immutability of data in the blockchain enhances transaction reliability, and promotes confidence on both sides of a given transaction. In another aspect, fully collateralized fiat coins (FCFC) residing within the blockchain are based on an underlying fiat currency. Within the blockchain, the FCFC are their own currency.
    Type: Application
    Filed: December 21, 2020
    Publication date: April 15, 2021
    Applicant: 9th Gear Technologies, Inc.
    Inventors: Maryanne Morrow, Katherine Maher, Andrew Fately, Jay Payne, Wyatt Barnes, John Gillespie
  • Publication number: 20210068293
    Abstract: A method for maintaining continuity of a network signal path extending along a backplane includes providing a bypass signal circuit compatible with the network signal path and being electrically connected in series with the first and second portions of the network signal path. The bypass signal circuit includes a normally open circuit portion and an electrical contact movable with respect to the bypass signal circuit. An electrical contact is mechanically moved out of contact with the bypass signal circuit and moved mechanically into contact with the bypass signal circuit in response to the function module being detached from or attached to the function module electrical connector and not in response to an electrical control signal.
    Type: Application
    Filed: November 3, 2020
    Publication date: March 4, 2021
    Inventors: Scott Michael Frye, Brian John Gillespie, JR., Christopher Michael Brink
  • Patent number: 10875868
    Abstract: Compounds of formula (I) that are capable of acting as purine receptor antagonists, pharmaceutical compositions including the compounds, and methods of making the compounds, are. disclosed. The compounds and compositions can be used in treating or preventing disorders related to purine receptor hyperfunctioning.
    Type: Grant
    Filed: December 2, 2019
    Date of Patent: December 29, 2020
    Assignee: VERNALIS (R&D) LIMITED
    Inventors: Samantha Jane Bamford, Roger John Gillespie, Richard Simon Todd
  • Publication number: 20200383368
    Abstract: The present invention provides food products, nutritional programs, and methods for meeting nutritional needs of subjects with dementia and related cognitive disorders. In one embodiment, the invention provides a food product comprising a reversibly sealed container and a soup, wherein the soup is in the container and comprises a total volume of 200-2000 mls, a vegetable or meat component, 300 to 2500 calories, a macronutrient caloric distribution comprising: 20-80% fat, 10-45% protein, and 10-65% carbohydrate, about 2% to about 40% medium chain triglycerides, omega 3 fatty acids in an amount of 100 to 2000 mg and less than 20 solid food particles having a volume greater than about 20 cm3.
    Type: Application
    Filed: April 14, 2020
    Publication date: December 10, 2020
    Applicant: D&E Gillespie Enterprises LLC
    Inventor: John Gillespie
  • Patent number: 10842039
    Abstract: A backplane or backplane module for transmitting data along a signal path of a network to one or more functional modules attached to the signal path includes a printed circuit board, a functional module electrical connector attached to the printed circuit board, and a mechanically actuated bypass circuit assembly that maintains signal continuity along the signal path when a function module is not attached to the function module electrical connector.
    Type: Grant
    Filed: September 17, 2018
    Date of Patent: November 17, 2020
    Assignee: Phoenix Contact Development and Manufacturing, Inc.
    Inventors: Scott Michael Frye, Brian John Gillespie, Jr., Christopher Michael Brink
  • Publication number: 20200344906
    Abstract: A backplane or backplane module for transmitting data along a signal path of a network to one or more functional modules attached to the signal path includes a printed circuit board, a functional module electrical connector attached to the printed circuit board, and a mechanically actuated bypass circuit assembly that maintains signal continuity along the signal path when a function module is not attached to the function module electrical connector.
    Type: Application
    Filed: September 17, 2018
    Publication date: October 29, 2020
    Inventors: Scott Michael Frye, Brian John Gillespie, JR., Christopher Michael Brink
  • Patent number: 10799268
    Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.
    Type: Grant
    Filed: April 10, 2018
    Date of Patent: October 13, 2020
    Assignee: SOLACE THERAPEUTICS, INC.
    Inventors: Kevin G. Connors, Ryan J. Cahill, Peter Dayton, John Gillespie, Jr.
  • Publication number: 20200253636
    Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.
    Type: Application
    Filed: January 13, 2020
    Publication date: August 13, 2020
    Inventors: Kevin G. Connors, Ryan J. Cahill, Peter Dayton, John Gillespie, JR.
  • Publication number: 20200172547
    Abstract: Compounds of formula (I) that are capable of acting as purine receptor antagonists, pharmaceutical compositions including the compounds, and methods of making the compounds, are. disclosed. The compounds and compositions can be used in treating or preventing disorders related to purine receptor hyperfunctioning.
    Type: Application
    Filed: December 2, 2019
    Publication date: June 4, 2020
    Applicant: Vernalis (R&D) Limited
    Inventors: Samantha Jane Bamford, Roger John Gillespie, Richard Simon Todd
  • Publication number: 20200163543
    Abstract: An implant delivery system can be configured to deliver an inflatable implant into a bladder via a urethra. The delivery system can comprise an elongate tubular body, an inflation tube and an implant decoupler. The tubular body can comprise a central lumen configured to hold an inflatable implant in an initial un-inflated state for delivery of the implant into the bladder. A method of use can include passing a distal tip of the elongate tubular body into the bladder. The implant can be inflated and released into the bladder.
    Type: Application
    Filed: July 3, 2019
    Publication date: May 28, 2020
    Inventors: Ernest George Schutt, Kevin G. Connors, John Gillespie, JR., Peter Dayton
  • Publication number: 20200139652
    Abstract: Elongate profiled object having a cross section, the object comprising a peripheral wall, forming a hollow profile extending in a longitudinal direction, wherein at least part of the peripheral wall is provided with a reinforcement element, and wherein the elongate profiled object is made of a thermoplastic material.
    Type: Application
    Filed: July 12, 2018
    Publication date: May 7, 2020
    Inventors: Curtis Collar, Talal Mansour Al-Safi, Abdul Rahim Ahamed Arafath, John Gillespie McCann
  • Patent number: 10617139
    Abstract: The present invention provides food products, nutritional programs, and methods for meeting nutritional needs of subjects with dementia and related cognitive disorders. In one embodiment, the invention provides a food product comprising a reversibly sealed container and a soup, wherein the soup is in the container and comprises a total volume of 200-2000 mls, a vegetable or meat component, 300 to 2500 calories, a macronutrient caloric distribution comprising: 20-80% fat, 10-45% protein, and 10-65% carbohydrate, about 2% to about 40% medium chain triglycerides, omega 3 fatty acids in an amount of 100 to 2000 mg and less than 20 solid food particles having a volume greater than about 20 cm3.
    Type: Grant
    Filed: April 29, 2018
    Date of Patent: April 14, 2020
    Assignee: D&E Gillespie Enterprises
    Inventor: John Gillespie
  • Patent number: 10543071
    Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and can include one or more of an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.
    Type: Grant
    Filed: August 8, 2013
    Date of Patent: January 28, 2020
    Assignee: SOLACE THERAPEUTICS, INC.
    Inventors: Ryan J. Cahill, Scott Duncan, Kevin G. Connors, William Gruber, John Gillespie, Jr., Sheila Caira
  • Patent number: 10538526
    Abstract: Compounds of formula (I) that are capable of acting as purine receptor antagonists, pharmaceutical compositions including the compounds, and methods of making the compounds, are disclosed. The compounds and compositions can be used in treating or preventing disorders related to purine receptor hyperfunctioning.
    Type: Grant
    Filed: September 15, 2018
    Date of Patent: January 21, 2020
    Assignee: Vernalis (R&D) Limited
    Inventors: Samantha Jane Bamford, Roger John Gillespie, Richard Simon Todd
  • Patent number: 10531894
    Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: January 14, 2020
    Assignee: Solace Therapeutics, Inc.
    Inventors: Kevin G. Connors, Ryan J. Cahill, Peter Dayton, John Gillespie, Jr.
  • Patent number: 10383510
    Abstract: An implant delivery system can be configured to deliver an inflatable implant into a bladder via a urethra. The delivery system can comprise an elongate tubular body, an inflation tube and an implant decoupler. The tubular body can comprise a central lumen configured to hold an inflatable implant in an initial un-inflated state for delivery of the implant into the bladder. A method of use can include passing a distal tip of the elongate tubular body into the bladder. The implant can be inflated and released into the bladder.
    Type: Grant
    Filed: October 14, 2016
    Date of Patent: August 20, 2019
    Assignee: SOLACE THERAPEUTICS, INC.
    Inventors: Ernest G. Schutt, Kevin G. Connors, John Gillespie, Jr., Peter Dayton
  • Patent number: 10363975
    Abstract: A method for locally reinforcing or baffling a structure having a hollow cavity is disclosed. The present invention provides an insert that includes a carrier, a thermally expandable material located on at least a portion of the carrier, and at least one integrally formed attachment that projects outwardly from the carrier. The inserts of the present invention are preferably placed within a hollow cavity in a transverse direction so that once the insert is sealed into place via the thermally expandable material, the hollow cavity is separated into two separate chambers.
    Type: Grant
    Filed: June 16, 2014
    Date of Patent: July 30, 2019
    Assignee: Zephyros, Inc.
    Inventors: Erin White, Eric N. White, John Gillespie, Olaf Nitsche
  • Publication number: 20190227055
    Abstract: The invention relates to compositions and methods for the concentration and/or purification of analytes, such as biomarkers, typically from complex biological samples such as whole blood, serum or plasma. This invention also relates to the use of binding agents, such as antibodies, aptamers, antigens and engineered protein scaffold based binding agents (e.g. commercially available Affibodies®), to facilitate the concentration and/or purification of said analytes. This invention further relates to assays used to detect, measure and/or quantify the analyte after its concentration and/or purification, preferably solid-phase immunoassays and more preferably multiplex solid-phase immunoassays.
    Type: Application
    Filed: January 18, 2019
    Publication date: July 25, 2019
    Inventors: Mark J. Lim, Heather P. Ostendorff, Zhi Wan, John Gillespie, Kenneth J. Rothschild
  • Publication number: 20190031668
    Abstract: Compounds of formula (I) that are capable of acting as purine receptor antagonists, pharmaceutical compositions including the compounds, and methods of making the compounds, are disclosed. The compounds and compositions can be used in treating or preventing disorders related to purine receptor hyperfunctioning.
    Type: Application
    Filed: September 15, 2018
    Publication date: January 31, 2019
    Applicant: Vernalis (R&D) Limited
    Inventors: Samantha Jane Bamford, Roger John Gillespie, Richard Simon Todd
  • Patent number: 10106547
    Abstract: Compounds of formula (I) that are capable of acting as purine receptor antagonists, pharmaceutical compositions including the compounds, and methods of making the compounds, are disclosed. The compounds and compositions can be used in treating or preventing disorders related to purine receptor hyperfunctioning.
    Type: Grant
    Filed: August 21, 2017
    Date of Patent: October 23, 2018
    Assignee: Vernalis (R&D) Limited
    Inventors: Samantha Jane Bamford, Roger John Gillespie, Richard Simon Todd